The expression of B4GALT1 has been known to quickly respond to estrogen treatment [6, 101], and the ERα-dependent activation of cell proliferation through membrane B4GALT1 implicated its crucial role in breast cancer development [102]. The gene discussed is ESR1; the disease is breast carcinoma.